ID24279A - Komposisi kering yang terlarut dalam air - Google Patents

Komposisi kering yang terlarut dalam air

Info

Publication number
ID24279A
ID24279A IDW20000294A ID20000294A ID24279A ID 24279 A ID24279 A ID 24279A ID W20000294 A IDW20000294 A ID W20000294A ID 20000294 A ID20000294 A ID 20000294A ID 24279 A ID24279 A ID 24279A
Authority
ID
Indonesia
Prior art keywords
amino acids
dry compositions
hydrophobic amino
defoaming agents
dry composition
Prior art date
Application number
IDW20000294A
Other languages
English (en)
Indonesian (id)
Inventor
Chikamasa Yamashita
Masaaki Odomi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of ID24279A publication Critical patent/ID24279A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20000294A 1998-06-26 1999-06-24 Komposisi kering yang terlarut dalam air ID24279A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18079698 1998-06-26

Publications (1)

Publication Number Publication Date
ID24279A true ID24279A (id) 2000-07-13

Family

ID=16089500

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000294A ID24279A (id) 1998-06-26 1999-06-24 Komposisi kering yang terlarut dalam air

Country Status (15)

Country Link
US (2) US6337067B1 (fr)
EP (1) EP1018345B1 (fr)
JP (1) JP4332694B2 (fr)
KR (1) KR100652943B1 (fr)
CN (1) CN100341575C (fr)
AT (1) ATE416790T1 (fr)
AU (1) AU760940B2 (fr)
CA (1) CA2301889C (fr)
DE (1) DE69940051D1 (fr)
DK (1) DK1018345T3 (fr)
ES (1) ES2317695T3 (fr)
HK (1) HK1028738A1 (fr)
ID (1) ID24279A (fr)
PT (1) PT1018345E (fr)
WO (1) WO2000000221A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758794B2 (en) 2001-10-29 2010-07-20 Princeton University Method of making an article comprising nanoscale patterns with reduced edge roughness
PT1254944E (pt) * 1999-12-24 2007-06-08 Otsuka Pharma Co Ltd Composições anidras contendo aminoácidos hidrofóbicos.
TWI232102B (en) 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP4610154B2 (ja) * 2002-05-30 2011-01-12 大塚製薬株式会社 注射用製剤
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
US20100217664A1 (en) * 2007-09-07 2010-08-26 Ryan Steelberg Engine, system and method for enhancing the value of advertisements
EP2236520A1 (fr) * 2009-03-31 2010-10-06 Leukocare Ag Composition de stabilisation pour biomolécules immobilisées
WO2011084816A1 (fr) * 2009-12-21 2011-07-14 Glanbia Nutritionals (Ireland) Ltd. Composition leucine/peptide et son procédé de formulation
CN104023743B (zh) 2011-10-25 2017-05-03 普罗西纳治疗有限公司 抗体制剂和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168008A3 (fr) 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Composition stable d'interféron-gamma
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
CN1045390C (zh) * 1994-06-16 1999-10-06 谭灿文 复合氨基酸冲剂
TW403653B (en) * 1995-12-25 2000-09-01 Otsuka Pharma Co Ltd Dry compositions

Also Published As

Publication number Publication date
US20010049361A1 (en) 2001-12-06
EP1018345A1 (fr) 2000-07-12
WO2000000221A1 (fr) 2000-01-06
KR20010023269A (ko) 2001-03-26
US6337067B1 (en) 2002-01-08
WO2000000221A9 (fr) 2000-07-27
EP1018345B1 (fr) 2008-12-10
CN1272795A (zh) 2000-11-08
EP1018345A4 (fr) 2005-01-26
CA2301889C (fr) 2008-02-19
CA2301889A1 (fr) 2000-01-06
ATE416790T1 (de) 2008-12-15
US6479048B2 (en) 2002-11-12
DK1018345T3 (da) 2009-03-23
JP4332694B2 (ja) 2009-09-16
PT1018345E (pt) 2009-01-23
ES2317695T3 (es) 2009-04-16
AU4392899A (en) 2000-01-17
CN100341575C (zh) 2007-10-10
KR100652943B1 (ko) 2006-12-01
HK1028738A1 (en) 2001-03-02
AU760940B2 (en) 2003-05-22
DE69940051D1 (de) 2009-01-22

Similar Documents

Publication Publication Date Title
AU4549989A (en) Aqueous ophthalmic solutions and method for preserving same
AU2001275305A1 (en) Rinse agent composition and method for rinsing a substrate surface
ES2041965T3 (es) Emulsiones silaniocas tamponadas para impartir propiedades hidrofobas en sustratos porosos.
CA2201749A1 (fr) Formulations de solutions d'interferon alpha aqueuses stables
MXPA03006999A (es) Composicion limpiadora espumante suave.
ID24279A (id) Komposisi kering yang terlarut dalam air
ATE108649T1 (de) Brausemischung, deren herstellung sowie verwendung.
KR890004765A (ko) 화장품 제제에서 사용하기 위한 증점된 수성 계면 활성제 용액
WO2002026277A3 (fr) Solutions stabilisees de peroxyde d'hydrogene
CA2095341A1 (fr) Composition d'herbicide amelioree a base d'acide gras
ES2124063T3 (es) Composiciones de microemulsiones de compuestos de 3-isotiazolonas.
BR0009214A (pt) Composições aquosas estáveis contendo umcomposto de silìcio
ATE335409T1 (de) Suesstoffzusammensetzung
FR2790953B1 (fr) Composition a phase aqueuse continue renfermant de l'acide l-2-oxothiazolidine 4-carboxylique
AU3546597A (en) Stabilised and buffered hydrogen peroxide solution, method for making same and use thereof for decontaminating contact lenses
JPS5762218A (en) Ophthalmic solution
CA2331076A1 (fr) Composition stable a base de diphenylcarbamide
TH20636B (th) สารต้านเชื้อราแบบผสม
JPS6452727A (en) Antiallergic eye drop
RU98109064A (ru) Глазные пленки
DK0553647T3 (da) Vandige polymerisatsammensætninger
CA2111314A1 (fr) Compositions algicides et herbicides
TH9141EX (th) ส่วนประกอบสำหรับรักษาเส้นผม